We are live on
!
Find out more
LP
LMR Partners Portfolio holdings
AUM
$45.4B
1-Year Est. Return
60.68%
This Fund
S&P 500
This Quarter
Est. Return
+23.27%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$11.9B
AUM Growth
-$665M
(-5.3%)
Cap. Flow
-$2.07B
Cap. Flow
% of AUM
-17.42%
Top 10 Holdings %
Top 10 Hldgs %
29.25%
Holding
1,790
New
534
Increased
200
Reduced
243
Closed
613
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$472M |
| 2 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$63M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$61M |
| 4 |
FYBR
Frontier Communications
FYBR
|
+$56.7M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$43.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$107M |
| 2 |
GSK
GSK
|
+$58.9M |
| 3 |
Broadcom
AVGO
|
+$54M |
| 4 |
Unilever
UL
|
+$54M |
| 5 |
Marvell Technology
MRVL
|
+$48.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.5% |
| 2 | Communication Services | 3.61% |
| 3 | Financials | 3.6% |
| 4 | Healthcare | 3.01% |
| 5 | Consumer Discretionary | 1.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVGOW
626
DELISTED
EVgo Inc Warrants
EVGOW
| $1.51M | 0.01% |
+2,819,066
| New | +$3.07M |
|
627
CALL
Macy's
M
$6.57B
| $1.5M | 0.01% |
88,500
| – | – |
|
628
BridgeBio Pharma
BBIO
$16.5B
| $1.49M | 0.01% |
54,430
-50,402
| -48% | -$1.3M |
|
629
CALL
Merck
MRK
$323B
| $1.49M | 0.01% |
15,000
| – | – |
|
|
630
Merck
MRK
$323B
| $1.49M | 0.01% |
14,995
| – | – |
|
631
Thermo Fisher Scientific
TMO
$208B
| $1.47M | 0.01% |
2,832
-10,158
| -78% | -$5.58M |
|
632
Tapestry
TPR
$29.8B
| $1.44M | 0.01% |
22,068
+22,058
| +220,580% | +$1.2M |
|
|
PONY
633
Pony AI Inc
PONY
$3.21B
| $1.44M | 0.01% |
+100,000
| New | +$1.33M |
|
634
Teva Pharmaceuticals
TEVA
$36.2B
| $1.43M | 0.01% |
+64,817
| New | +$1.18M |
|
635
TripAdvisor
TRIP
$1.66B
| $1.42M | 0.01% |
96,007
-79,646
| -45% | -$1.16M |
|
636
Archer Daniels Midland
ADM
$40.1B
| $1.41M | 0.01% |
+27,878
| New | +$1.51M |
|
637
CALL
Salesforce
CRM
$142B
| $1.4M | 0.01% |
+4,200
| New | +$1.34M |
|
638
PUT
ASML
ASML
$636B
| $1.39M | 0.01% |
2,000
-100
| -5% | -$71.8K |
|
639
Cigna
CI
$77B
| $1.39M | 0.01% |
+5,017
| New | +$1.6M |
|
640
CALL
Mondelez International
MDLZ
$77.9B
| $1.37M | 0.01% |
22,900
| – | – |
|
641
PUT
Johnson Controls International
JCI
$87.5B
| $1.35M | 0.01% |
17,100
-1,300
| -7% | -$104K |
|
642
Insulet
PODD
$11.4B
| $1.35M | 0.01% |
5,155
-9,956
| -66% | -$2.51M |
|
643
PUT
MetLife
MET
$61.2B
| $1.34M | 0.01% |
16,400
-21,500
| -57% | -$1.79M |
|
644
Amer Sports
AS
$20.5B
| $1.34M | 0.01% |
+48,000
| New | +$1.06M |
|
645
Toronto Dominion Bank
TD
$198B
| $1.29M | 0.01% |
+24,143
| New | +$1.35M |
|
646
Linde
LIN
$234B
| $1.28M | 0.01% |
+3,063
| New | +$1.4M |
|
647
iShares US Real Estate ETF
IYR
$4.73B
| $1.27M | 0.01% |
+13,668
| New | +$1.35M |
|
648
PUT
Kinder Morgan
KMI
$70.6B
| $1.27M | 0.01% |
46,300
-99,400
| -68% | -$2.59M |
|
649
State Street SPDR S&P Metals & Mining ETF
XME
$3.96B
| $1.27M | 0.01% |
22,314
+22,104
| +10,526% | +$1.42M |
|
650
Alpha Metallurgical Resources
AMR
$1.85B
| $1.26M | 0.01% |
+6,310
| New | +$1.41M |
|
Similar funds
AS
TI
LMR Partners's Q4 2024 Portfolio in Review
As of Q4 2024, LMR Partners held 1,790 positions worth $11.9B, down 5.3% from $12.6B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
LMR Partners withdrew a net $2.07B in Q4 2024, closing 613 positions and reducing 243 holdings. Its most notable exit was Unilever, an estimated $54M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Communication Services and Financials.
Against the trend, LMR Partners opened a new position in Vertex Pharmaceuticals worth $37.8M.
- LMR Partners's largest Q4 2024 buy was Vertex Pharmaceuticals: 93,801 shares worth $37.8M.
- LMR Partners added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $472M increase.
- LMR Partners's biggest Q4 2024 reduction was TSMC, cutting an estimated $107M.
- LMR Partners fully exited Unilever in Q4 2024, selling an estimated $54M.
- LMR Partners's ten largest holdings make up 29% of its $11.9B portfolio in Q4 2024.
- LMR Partners opened 534 new positions and closed 613 in Q4 2024.
- LMR Partners's portfolio value fell 5.3% quarter-over-quarter to $11.9B.
Based on LMR Partners's 13F filing for Q4 2024, filed 14 Feb 2025.